Affinity Asset Advisors LLC Has $12.87 Million Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Affinity Asset Advisors LLC lessened its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 3.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 279,445 shares of the company's stock after selling 11,002 shares during the quarter. Establishment Labs makes up about 1.7% of Affinity Asset Advisors LLC's portfolio, making the stock its 18th biggest position. Affinity Asset Advisors LLC owned approximately 1.00% of Establishment Labs worth $12,874,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the stock. William Blair Investment Management LLC lifted its position in Establishment Labs by 44.1% during the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock valued at $37,447,000 after acquiring an additional 248,888 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of Establishment Labs in the fourth quarter worth $12,898,000. Portolan Capital Management LLC raised its stake in shares of Establishment Labs by 243.1% in the fourth quarter. Portolan Capital Management LLC now owns 193,991 shares of the company's stock worth $8,937,000 after purchasing an additional 137,458 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Establishment Labs in the fourth quarter worth $5,494,000. Finally, Royce & Associates LP acquired a new stake in shares of Establishment Labs during the 4th quarter valued at about $4,862,000. 72.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ESTA has been the subject of a number of research analyst reports. Needham & Company LLC began coverage on Establishment Labs in a report on Monday, April 14th. They set a "hold" rating for the company. Stephens reiterated an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, Establishment Labs presently has a consensus rating of "Moderate Buy" and a consensus price target of $57.40.

Establishment Labs Stock Performance

Establishment Labs stock traded up $1.27 during trading hours on Friday, hitting $31.45. The stock had a trading volume of 558,088 shares, compared to its average volume of 453,948. The company has a market cap of $907.21 million, a PE ratio of -12.19 and a beta of 0.77. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a fifty-two week low of $26.56 and a fifty-two week high of $60.12. The company has a 50-day moving average of $36.56 and a two-hundred day moving average of $39.69.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). The business had revenue of $44.51 million for the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. On average, equities research analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.